Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HER2-positive Early Breast Cancer × Taxes × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 85 Pancreatic Neoplasms 75 Carcinoma, Non-Small-Cell Lung 71 Ovarian Neoplasms 41 Fallopian Tube Neoplasms 39 Triple Negative Breast Neoplasms 34 Lung Neoplasms 25 Neoplasm Metastasis 24 Squamous Cell Carcinoma of Head and Neck 20 Breast Neoplasms, Male 17 Endometrial Neoplasms 16 Stomach Neoplasms 15 Neoplasms 15 Brenner Tumor 15 Carcinoma, Ovarian Epithelial 14 Uterine Cervical Neoplasms 13 Melanoma 13 Esophageal Neoplasms 12 Adenocarcinoma of Lung 10 Cholangiocarcinoma 9 Urinary Bladder Neoplasms 8 Unspecified Adult Solid Tumor, Protocol Specific 8 Inflammatory Breast Neoplasms 7 Colorectal Neoplasms 7 Carcinoma, Transitional Cell 7 Adenocarcinoma, Bronchiolo-Alveolar 7 Adenocarcinoma Of Esophagus 7 Oropharyngeal Neoplasms 6 Mouth Neoplasms 6 Adenocarcinoma 6

Interventions

Trastuzumab 4 pertuzumab 3 Docetaxel 3 Carboplatin 3 pyrotinib 1 Taxes 1 Surgical Procedures, Operative 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340398 2026-01-21

TAYLOR

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting

HER2-positive Early Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡